Search Articles and Web Sources

Search Results

In this project

TurboQuant: 3-bit KV-cache for LLM without losses

https://sudonull.com/turboquant-3-bit-kv-cache-for-llm-without-losses

Learn how Google TurboQuant compresses key-value cache of LLM to 3 bits, speeding up inference 8x. Benchmarks on Gemma/Mistral, application in RAG. For developers.

Multithreading in Go: CPU, caches and performance | Analysis

https://sudonull.com/multithreading-in-go-cpu-caches-and-performance-analysis

How cache hierarchy and MESI protocol affect Go applications. Practical recommendations for optimizing multithreaded code. Learn more!

B-trees: cache efficiency and data structure optimization

https://sudonull.com/b-trees-cache-efficiency-and-data-structure-optimization

Learn how B-trees improve data structure performance by minimizing cache misses. Analysis of benchmarks, order, and applications of B+ trees.

How to Design a Scalable Web Application Architecture

https://sudonull.com/how-to-design-a-scalable-web-application-architecture

Learn how to design a scalable web application architecture with practical strategies for statelessness, database sharding, caching, and observability. Expert guide with actionable steps.

Web Application Vulnerabilities: XSS SQLi enumeration

https://sudonull.com/web-application-vulnerabilities-xss-sqli-enumeration

Breakdown of top-3 vulnerabilities in web: user enumeration, XSS, SQL injections. Fix methods for developers: prepared statements, encoding. In-depth pentest guide.

From other projects

Pediatric Dovato: EMA Approves Application for HIV Therapy

https://ymaho.com/pediatric-dovato-ema-approves-application-for-hiv-therapy

EMA validated the application for pediatric Dovato (dolutegravir/lamivudine) for children from 2 years old. Learn how two-drug therapy is changing HIV treatment standards.

EMA accepted the application for Dovato for children with HIV

https://ymaho.com/ema-accepted-the-application-for-dovato-for-children-with-hiv

EMA validated the application for the use of Dovato in children from 3 months with HIV. Learn how this will change pediatric therapy and strengthen ViiV's position. Read the detailed analysis.

Pediatric Dovato: ViiV application and geopolitics of the HIV market

https://ymaho.com/pediatric-dovato-viiv-application-and-geopolitics-of-the-hiv-market

ViiV has submitted applications to the FDA and EMA for dispersible Dovato tablets for children. We analyze the strategy, patents, and implications. Find out who will win.

Study of the Ottava robot: FORTE results and FDA application

https://ymaho.com/study-of-the-ottava-robot-forte-results-and-fda-application

Scientists have completed the pivotal study of the Ottava robot (FORTE) and are preparing an FDA application. Learn about clinical data, zero conversions, and market prospects for robotic surgery.

Gene therapy for deafness otarmeni EMA: accelerated review 2026

https://ymaho.com/gene-therapy-for-deafness-otarmeni-ema-accelerated-review-2026

EMA accepted the application for gene therapy otarmeni for the treatment of hereditary deafness OTOF. Market analysis, forecasts, price and implications for the industry. Read.

SpaceX IPO: filing for $75 billion and valuation of $1.75 trillion

https://ymaho.com/spacex-ipo-filing-for-75-billion-and-valuation-of-1-75-trillion

SpaceX filed an application for the largest IPO in history on Nasdaq up to $75 billion. Valuation $1.75 trillion, listing in June 2026. Analysis of the record, consequences and hidden details. Read more.

Intellia CRISPR therapy: FDA filing for lonvo-z for HAE

https://ymaho.com/intellia-crispr-therapy-fda-filing-for-lonvo-z-for-hae

Intellia has filed the world's first application for an in vivo CRISPR therapy, lonvo-z, for hereditary angioedema (HAE). 87% reduction in attacks, 62% attack-free. Risk, market, and forecast analysis. Read.

Linlithgow Rose SPFL Play-Off Exclusion Due to Licence

https://lrivo.com/linlithgow-rose-spfl-play-off-exclusion-due-to-licence

Linlithgow Rose miss SPFL play-offs after SFA bronze licence application declined. Brora Rangers face Edinburgh City in final. Learn why.

AI for early diagnosis of gallbladder cancer: accuracy 92-97%

https://ymaho.com/ai-for-early-diagnosis-of-gallbladder-cancer-accuracy-92-97

PGIMER AI model analyzes ultrasound and detects gallbladder cancer at an early stage. Free application for hospitals. Data from The Lancet. Learn more.

IPO of UzNIF: Uzbekistan's entry onto the London Stock Exchange for $1.95 billion

https://ymaho.com/ipo-of-uznif-uzbekistan-s-entry-onto-the-london-stock-exchange-for-1-95-billion

Dual IPO of Uzbekistan's National Fund for $1.95 billion in Tashkent and London. GDR price — $25. Submit your application by May 12 and learn the placement details.